Ginseng Nonsuperior to Placebo in Improving Quality of Life in COPD
Ginseng is nonsuperior to placebo for improving health-related quality of life in patients with stable symptomatic COPD.
Chronic Obstructive Pulmonary Disease
FDA Approves First Generic Version of Advair for Asthma, COPD
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the US FDA.
Algorithm Reduces Antibiotic Use in Lower Respiratory Tract Infection
The duration of antibiotic regimens to treat lower respiratory tract infection can be reduced through the use of a procalcitonin-guided algorithm.
Vitamin D Supplementation Can Help Cut COPD Exacerbations
Review shows supplementation only effective for baseline vitamin D levels 25 nmol/L.
Cognitive Therapy Helps Reduce Anxiety in COPD Patients
Cognitive behavioral therapy delivered by respiratory nurses is associated with reduced anxiety symptoms and is cost-effective for patients with chronic obstructive pulmonary disease
COPD Tied to Obesity in Male, Female Never-Smokers
Strong dose-response relationship seen in never-smokers aged 50 and older.
Patients Hospitalized for COPD Rarely Receive Pulmonary Rehab
Elderly, those living 10 miles from facility, those with lower SES less likely to receive pulmonary rehab.
Metered Dose Inhaler Errors Affect Many With COPD and Asthma
The most common error related to the use of metered dose inhalers was the failure to attach the inhaler to a spacer.
Long-Term Benzodiazepines Do Not Increase Mortality in COPD, PTSD
For patients with chronic obstructive pulmonary disease and comorbid posttraumatic stress disorder, long-term benzodiazepine use is not associated with mortality, but there is an association for short-term benzodiazepine use.
Small Reduction in Lung Function With Treatment De-Escalation in COPD
No difference in exacerbations with indacaterol/glycopyrronium for non-frequently exacerbating COPD.
Next post in Pulmonology Information Center
